A Vancouver-based biotech company brought its genetic know-how to Pfizer’s COVID-19 vaccine development. Thomas Madden, president and CEO of Acuitas Therapeutics, explains his company’s contribution to the vaccine effort.
Categories
B.C. biotech company working on Pfizer COVID-19 vaccine